News Archive

Shortened Three-month DAPT Duration After PCI Demonstrates Low Rate of Adverse Events in High-Bleeding Risk Patients
Biodegradable Polymer Everolimus-eluting Stent with Shortened DAPT is Safe and Effective for PCI in Patients with Unprotected Left Main Coronary Artery Disease
Durable Polymer Drug-Eluting Stent Noninferior to a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated with One-Month DAPT
Ticagrelor Without Aspirin Three Months After Successful PCI and DAPT Reduces Major Bleeding Without Increasing the Risk of Adverse Events
TCT 2019 Career Achievement Award to be Presented to Robert O. Bonow, MD, MS
CRF Fellow Publishes Research Letter Examining Pulmonary Embolism Outcomes in JAMA
Announcing the TCT 2019 Late-Breaking Trials and Science
TCT 2019 Agenda Now Available
CRF And VEITHsymposium Announce an Alliance Between Transcatheter Cardiovascular Therapeutics (TCT) and VEITHsymposium
Late-Breaking Science Announced for TVT 2019

Press Contacts

Irma Damhuis
Director, External Relations
Tel: 646-434-4690

Judy Romero
Associate Director, External Relations
Tel: 646-434-4608
press@crf.org